RETHINKING NEEDS-DRIVEN INNOVATION FROM THE SOUTH Access to Essential Medicines Initiative Seminar Public Health Program – Open Society Foundation (OSF)

Slides:

Advertisements

Similar presentations

Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.

Advertisements

Personalized Medicine in California Kathryn Lowell, Deputy Secretary for Life Sciences and Health Systems February, 2009.

Professor Dave Delpy Chief Executive of Engineering and Physical Sciences Research Council Research Councils UK Impact Champion Competition vs. Collaboration:

Funding Excellence in Research Mark Walport 2 December 2010.

Biomedical Engineering Initiative: Creating the next generation of healthcare innovators in Africa Muhammad H. Zaman Director, LEED, Boston University.

Croydon Clinical Commissioning Group An introduction.

Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,

The Booming Business of Biotechnology Barbara Lano Rummel Lindquist & Vennum PLLP ©2006 Lindquist & Vennum.

NCI Designation: Expanding Science and Promoting Health in the Region Name Title, Company Date.

1. 2 University of Sydney Engaging with Asia 3 University of Sydney proposal to establish a 100% foreign- owned Clinical School in Vietnam Part of University’s.

Penn’s Innovations and the Global Poor Facilitating Access to Medicines in Developing Countries Universities Allied for Essential Medicines 22 Mar 2006.

NCI Center for Global Health Jo Anne Zujewski, M.D. September 11, 2014 Dar es Salaam, Tanzania.

Almost 14 years ago all countries endorsed a set of 8 Millennium Development Goals (or MDGs). 3 of those 8 Goals focus on health – that being child mortality,

Health Professional Students AIDS Advocacy Network Treat the People: Access to Essential AIDS Medications A Primer for Health Professional Students.

A Theory of Industrial Development Rostow’s Model of Development.

The Legislative Roadmap to Create Jobs, Expand Markets and Compete in the Global Economy The 2007 Innovation Plan.

Aboriginal Access to Health Care Systems Ontario Aboriginal Health Advocacy Initiative.

Centre for Innovation, Technology Transfer and University Development Jagiellonian University Centre for Innovation, Technology Transfer and University.

Portfolio Committee Presented by: Dr Phil Mjwara, Director General, DST Portfolio Committee 20 November 2007.

The Millennium Science Initiative Promoting Science and Technology Capacity for Development Michael Crawford May 14, 2004.

Ionia County Great Start Collaborative Strategic Planning Reviewing trends from new information & data Setting Priorities for Goals & Strategies.

Nathan Tinker Executive Director New York Biotechnology Association New York BizBio 2009 Fighting for a Healthy Biotech Industry.

Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,

Globalization means expanding our company business dealings all over the world. It is a good move for the company as it opens new trading opportunities.

1 National innovation systems Sub-regional seminar on the commercialization and enforcement of intellectual property rights Skopje, Macedonia April.

Health and Productivity Management: Investing in National Health and Competitiveness Healthy Lifestyle Forum | Moscow, Russia | 9 December 2013 Sean Sullivan,

NHPA’s. What are they? National Health Priority Areas (NHPAs) are diseases and conditions chosen for focused attention at a national level because of.

Live, work, grow in Pearland, Texas… CoreNet Global 2005 Economic Development Leadership and Innovation Finalist CoreNet Global 2005 Economic Development.

1 EU-funded health research activities against TB: FP6 actions and perspectives toward FP7 DG Research - European Commission 22 MARCH 2007.

Name Institution Date. Description of the Target Population The target population for this study are the African- American population aged between

Module 2 - Epidemiology of Tuberculosis

Clinical trials in Framework programme 7 (FP7) EU Judita Kinkorová 2. Národní konference o doporučených postupech, Olomouc 13. listopadu 2010.

L THE EXPLODING GLOBAL HIV/AIDS PANDEMIC. l THE POTENTIAL ENORMITY OF THE HIV/AIDS PANDEMIC IS PROFOUND.

ACCESS TO TREATMENT IN SOUTH AFRICA: A CALLTO ACTION UICC WORLD CANCER LEADERS SUMMIT: PARTNER EVENT: ACCESS TO TREATMENT IN LMIC.

Donors, prize funds and patent pools. KEI & UNU- MERIT Maastricht Workshop on Medical Innovation Prizes January 28th-29th 2008 Michelle Childs, Head of.

Improving Population Health through Effective Public-Private Partnerships LaQuandra S. Nesbitt, MD, MPH Director, DC DOH October 27, 2015.

HORIZON 2020 SC1-Health, demographic change and wellbeing challenge Марина Николовска Министерство за образование и наука

Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.

HUMAN-BASED ECONOMY Largest IT engineering force in CEE: manufacturing, engineering students 40% of R&D Legacy of Soviet Union 2.5 billion and.

Topic: World Health Threats

PIRE I & II Post-Award Activities OISE PO team working --To help make the projects succeed, --To help OISE and all of NSF learn more about the projects,

Economic Development and Transition Chapter 18. Levels of Development  Developed Nations –Northern countries –Industrial countries –First and Second.

A Developing World: Comparing Countries and Economies

Rome Donors Meeting September 7th1 Consultation of AMC concept with key stakeholders Rome Donors Meeting September 7 th, 2006.

Warm Up What do you think causes the economies of some less developed nations to grow rapidly?

Future Challenges. Barrier to the expansion of health psychology  Costs of the services.

Projected Population and HIV/AIDS Update 18 May 2011 National Health Insurance Policy Brief 18.

Communicable Diseases Alan J. Parkinson, Deputy Director Arctic Investigations Program, Centers for Disease Control & Prevention, USA.

Clinical research in Sweden Current state and prospective Olle Stendahl, MD, PhD Dept. Molecular and Clinical Medicine Faculty of Health Sciences Linköping.

2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.

CONFIDENTIAL 0 0 Paul Stoffels, M.D. Chief Scientific Officer Worldwide Chairman, Pharmaceuticals.

East African Science and Technology Commission (EASTECO) East African Science and Technology Commission (EASTECO) East African Science and Technology Commission.

Support for Innovation in Iran

A Story of Two Countries Biotechnology Industry

The Impact of Chronic Disease on a Future NHI

ECONOMIC AND INDUSTRY PERSPECTIVES

Leader of R & D Project Management

Irish Forum for Global Health Conference 2012 Closing Session

Science and Technology

The World Health Organization

THE EXPLODING GLOBAL HIV/AIDS PANDEMIC

The Impact of Chronic Disease on a Future NHI

Theme: 4 Employment and Economic Growth Department of Labour

Medicine in third world countries

South Africa – Sweden University Forum (SASUF)

　Department of Commerce, Industry and Labor Policy Outline and FY 2018 Major Efforts Policy Goals Enhancement of global competitiveness of Osaka industry.

Group One How would we increase the alignment of the SDG’s with The National Development Plan (NDP).

ICT Business Plan Representatives: Mteto Nyati. -

An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,

An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,

Presentation transcript:

RETHINKING NEEDS-DRIVEN INNOVATION FROM THE SOUTH Access to Essential Medicines Initiative Seminar Public Health Program – Open Society Foundation (OSF) Cape Town, South Africa Dec , 2010 Thank you

Bioscience serving Vietnam

- Young country: 60% of the Vietnamese population is under 35 years old - A high regard for education: 90% literacy rate - Fast growing investments: The Vietnamese government has recently approved the establishment and/or expansion of fifteen industrial zones (IPs) in the first half of These new and expanded IPs add to the more than 130 IZs on 26,500 ha, attracting 4,516 projects valued at $18 billion in foreign capital and $6.4 billion in domestic capital. Background on the Recent Development of Vietnam

Biotech Development and Heath Care Issues of Vietnam It is important for Vietnamese researchers to investigate the country's medical problems using the sophisticated tools of biotechnology. The problems have long had major negative impacts on the quality of life and the productivities of the people of Vietnam. They include: - The epidemic and endemic of different forms of flu annually - The effects of environment changes and chemicals such as dioxin and other contaminants on the increased incidence of cancer, birth defects, and countless of immune disorders - The increased developments of diabetics, obesity and heart diseases of different forms due to the rapid alterations of life styles and diets - The ever changing of bacterial, viral resistance to drug treatments of tuberculosis, malaria, hepatitis, HIV etc.

Characteristics of Vietnam Biotechnology A- Stages - Initial stage ( ): Acquaintance with biotech sciences, limited application - Progressive development ( ): Gradual applications of biotechnologies - Rapid changes ( ): Booming of ideas and research activities, but low productivity B - Characteristics - Product-driven - Establishing standardized biotechnology - In search for direction/development to make biotech a powerhouse for modernizing Vietnam health care C- Potentials for Biotech development - Rapid economic expansion - Young and highly motivated mentality - Skillful workers & cost effective services - Rich natural resources & research objectives

Nam-Khoa : The First Vietnam Biotech Company (Partner of Bioland Inc., Seoul, Korea) Bio-chip Real time PCR

MAMPROTECH VIETNAM

WHO 2000

Proposed Future Development of Vietnam Biotech in promoting a Health Needs-Driven Model for Broad Service of the Vietnamese Population - Building of a strong infrastructure for R&D toward neglected diseases (vs. R&D programs of developed countries). - Expanding intramural and extramural funding via government incentive policies - Focusing on productions and industrialization for lower costs but higher services. - Increasing international collaborations and investment partnerships with OSI, A-IMBN, GHS-UCSF etc. - Promoting awareness of needs-driven model among research teams within Vietnam